Congenital thrombotic thrombocytopenic purpura (TTP) typically develops in infancy or early childhood, but clinicians have now reported a rare case involving a young woman…
News
A group of U.S. treatment centers worked together to standardize care for children with immune thrombocytopenia (ITP), leading to more patients receiving treatment that…
A woman in her 40s with persistent heavy menstrual bleeding was safely treated with surgery after doctors diagnosed her with von Willebrand disease (VWD),…
People with thrombotic thrombocytopenic purpura (TTP) who are hospitalized on weekends face no increased risk of worse outcomes than those admitted on weekdays, according…
A 67-year-old woman in Japan experienced repeated relapses of immune thrombocytopenia (ITP) after treatment for her Cushing’s syndrome sharply lowered her hormone cortisol levels,…
Expectant mothers with von Willebrand disease (VWD) are more than 12 times more likely to require a blood transfusion during delivery than those without…
A lack or delayed response to Cablivi (caplacizumab-yhdp), when used alongside standard therapy to treat acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP), was…
U.S. researchers have created a prediction tool — one that uses laboratory tests collected at the time of diagnosis — to help identify which children…
The National Bleeding Disorders Foundation (NBDF) will be leading efforts this March — during Bleeding Disorders Awareness Month, simply called BDAM — to provide…
Researchers are developing a potential treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) that promotes immune tolerance rather than immunosuppression, according to a study. The…
